Infectious Diseases Epidemiology Unit, National Center for Epidemiology Surveillance e Health Promotion (CNESPS), Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
Infectious Diseases Epidemiology Unit, National Center for Epidemiology Surveillance e Health Promotion (CNESPS), Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
Vaccine. 2014 Feb 3;32(6):639-44. doi: 10.1016/j.vaccine.2013.12.012. Epub 2013 Dec 25.
Despite being a completely preventable disease, tetanus cases continue to occur in Italy and notification and hospitalization rates have been reported to be higher with respect to European and other industrialized countries. We examined statutory notification, hospitalization, mortality and seroprevalence data to describe tetanus epidemiology in Italy from 2001 to 2010. A total of 594 tetanus cases were notified, with an average annual incidence of 1.0/1,000,000 population. Most cases were unvaccinated or incompletely vaccinated. Eighty percent of cases occurred in subjects aged >64 years and a higher proportion of females with respect to males were reported in this age group. The annual number of hospital admissions was 1.4-1.7 times greater than the number of notifications in the same year. The mean annual number of reported deaths was 21. Seroprevalence data show progressively higher susceptibility levels with increasing age. Over 50% of persons aged 45-64 years and over two thirds of subjects ≥65 years had tetanus antibody levels <0.01 IU/ml. Results show that tetanus is a continuing problem in Italy and, as in other countries, most cases occur in older adults, especially elderly women. The observed differences in notification and hospitalization rates suggest underreporting by physicians. In recent years, Italy has accounted for most cases reported annually in the European Union (EU) but different case definitions are used. In Italy, a confirmed case is one that meets the clinical case definition while the EU case definition classifies confirmed cases as those with laboratory confirmation of disease. The incidence of clinical tetanus in Italy is ten-fold higher than in other industrialized countries, like Australia and Canada, likely due to higher susceptibility levels in Italy. In view of the low prevalence of tetanus antibodies in adults ≥45 years, strategies to improve vaccine uptake in this population group need to be implemented.
尽管破伤风是一种完全可以预防的疾病,但在意大利仍有破伤风病例发生,而且与欧洲和其他工业化国家相比,意大利的破伤风通报率和住院率都较高。我们检查了法定通报、住院、死亡率和血清流行率数据,以描述 2001 年至 2010 年意大利的破伤风流行病学。共通报了 594 例破伤风病例,年发病率为 1.0/100 万。大多数病例未接种或未完全接种疫苗。80%的病例发生在年龄>64 岁的人群中,在该年龄组中,女性病例的比例高于男性。同年住院人数比通报人数多 1.4-1.7 倍。报告的年平均死亡人数为 21 人。血清流行率数据显示,随着年龄的增长,易感性水平逐渐升高。超过 50%的 45-64 岁人群和三分之二以上的≥65 岁人群的破伤风抗体水平<0.01 IU/ml。结果表明,破伤风在意大利仍然是一个持续存在的问题,与其他国家一样,大多数病例发生在老年人中,尤其是老年女性。通报和住院率的差异表明医生的报告不足。近年来,意大利占欧盟(EU)每年报告病例的大部分,但使用的病例定义不同。在意大利,确诊病例是符合临床病例定义的病例,而欧盟的病例定义将确诊病例归类为有疾病实验室确诊的病例。意大利的临床破伤风发病率是其他工业化国家(如澳大利亚和加拿大)的十倍,可能是由于意大利的易感性水平较高。鉴于≥45 岁成年人破伤风抗体的低流行率,需要在该人群中实施提高疫苗接种率的策略。